All Pharma News
OncoSec Announces $2 Million Registered Direct Offering Under Nasdaq Rules

OncoSec Announces $2 Million Registered Direct Offering Under Nasdaq Rules
PR NEWSWIRE
10 Apr 2023
Share Share
OncoSec blindsided as blinded review reveals Keytruda combo flop

OncoSec blindsided as blinded review reveals Keytruda combo flop
Nick Paul Taylor FIERCE BIOTECH
04 Apr 2023
Share Share
Penny stock, Merck partner lays off 45% of staff to reach PhII readout by 2023

Penny stock, Merck partner lays off 45% of staff to reach PhII readout by 2023
Max Gelman ENDPTS
05 Oct 2022
Share Share
OncoSec sheds 45% of staff to fund IL-12 through Keytruda trial

OncoSec sheds 45% of staff to fund IL-12 through Keytruda trial
James Waldron FIERCEBIOTECH
05 Oct 2022
Share Share
OncoSec collaborates with Merck for KEYNOTE-C87 phase 3 trial

OncoSec collaborates with Merck for KEYNOTE-C87 phase 3 trial
PHARMABIZ
08 Jul 2021
Share Share
OncoSec collaborates with Merck for KEYNOTE-C87 phase 3 trial

OncoSec collaborates with Merck for KEYNOTE-C87 phase 3 trial
PHARMABIZ
08 Jul 2021
Share Share
OncoSec to Present Encore Interim Data from the KEYNOTE-695

OncoSec to Present Encore Interim Data from the KEYNOTE-695
PRNEWSWIRE
16 Apr 2021
Share Share
OncoSec Medical Sponsoring KOL Webinar On A High Unmet Medical Need: Anti-PD-1

OncoSec Medical Sponsoring KOL Webinar On A High Unmet Medical Need: Anti-PD-1
ONCOSEC
25 Mar 2021
Share Share
OncoSec Announces Publication in Clinical Cancer Research of Data Supporting

OncoSec Announces Publication in Clinical Cancer Research of Data Supporting
PRNEWSWIRE
01 Mar 2021
Share Share
OncoSec Strengthens Management Team With Two New Appointments

OncoSec Strengthens Management Team With Two New Appointments
PRNEWSWIRE
02 Feb 2021
Share Share